DSE : SILCOPHL

Silco Pharmaceuticals Limited — Company profile

Pharmaceutical Preparations · Bangladesh

Last price 14.8 BDT (At close: Oct 29, 2026) · Market cap 1.54B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Company profile

Silco Pharmaceuticals Limited engages in manufacturing, distribution, and marketing of finished pharmaceutical products in Bangladesh. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxatives, lipid lowering agents, mycolytic expectorants, and NSAIDs, as well as anti-inflammatory, narcotics, and multi-medicines. The company also exports its medicines to Afghanistan, Bhutan, Myanmar, Ivory Coast, Kenya, Mauritius, Somalia, Tanzania, and Uganda. Silco Pharmaceuticals Limited was incorporated in 1995 and is headquartered in Sylhet, Bangladesh.

Details

NameSilco Pharmaceuticals Limited
IndustryPharmaceutical Preparations
Employees313
Founded1995
CeoMd. Haque Rukan
CountryBangladesh
ExchangeDhaka Stock Exchange
Fiscal YearJuly - June
Reporting CurrencyBDT
IsinBD0495SILCO6
Sic2834

Key executives

NameTitle
Md. Haque RukanChief Executive Officer
Md. AlamChief Financial Officer

Contact

AddressNurani-41, Sylhet, 3100, Bangladesh
Phone880 299 663 8241
Websitehttps://www.silcopharma.com